Is neoadjuvant chemotherapy a realistic alternative to primary surgery for women with advanced ovarian cancer? Article

Steed, H, Oza, A, Murphy, J et al. (2004). Is neoadjuvant chemotherapy a realistic alternative to primary surgery for women with advanced ovarian cancer? . JOURNAL OF CLINICAL ONCOLOGY, 22(14_suppl), 5043-5043. 10.1200/jco.2004.22.14_suppl.5043

cited authors

  • Steed, H; Oza, A; Murphy, J; Laframboise, S; De Petrillo, D; Sturgeon, J; Rosen, B

authors

publication date

  • July 15, 2004

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Cancer
  • Clinical Research
  • Orphan Drug
  • Ovarian Cancer
  • Rare Diseases
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 5043

end page

  • 5043

volume

  • 22

issue

  • 14_suppl